What causes fmf

Overview

Familial Mediterranean Fever (FMF) is a chronic, inherited autoinflammatory disease that causes recurrent episodes of fever and inflammation. These episodes, often referred to as attacks, can affect various parts of the body, most commonly the abdomen, chest, and joints. While it is called "Mediterranean Fever," it affects people of various ethnic backgrounds, though it is most prevalent in populations originating from the Mediterranean basin, such as Turks, Armenians, Ashkenazi Jews, and Arabs. The condition is a genetic disorder, meaning it is passed down through families.

What Causes FMF?

The root cause of FMF lies in genetic mutations. Specifically, FMF is caused by mutations in a gene called MEFV. This gene is located on chromosome 16 and provides the body with instructions for making a protein known as pyrin. The pyrin protein is crucial in regulating the body's inflammatory response. It acts as a key component of the inflammasome, a protein complex that triggers the release of inflammatory cytokines, such as interleukin-1 (IL-1). In individuals with FMF, these MEFV gene mutations lead to a dysfunctional pyrin protein. This malfunctioning protein results in an overactive inflammasome, causing the inappropriate and excessive release of inflammatory mediators. This dysregulation leads to the characteristic recurrent inflammatory attacks experienced by people with FMF.

The Role of the MEFV Gene and Pyrin Protein

The MEFV gene plays a critical role in maintaining immune system balance. The pyrin protein it encodes is involved in sensing cellular stress and damage, initiating a controlled inflammatory response to deal with threats like infections. However, when the MEFV gene is mutated, the pyrin protein can become unstable or misfolded. This leads to spontaneous activation of the inflammasome, even in the absence of any real danger. This uncontrolled inflammation is the hallmark of FMF. There are several known mutations in the MEFV gene, with the most common and severe ones being M694V, M680I, M694I, and V726A. Different mutations can influence the severity and frequency of attacks, as well as the risk of developing amyloidosis, a serious complication.

Inheritance Pattern of FMF

FMF is an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated MEFV gene – one from each parent – to develop the condition. If a person inherits only one copy of the mutated gene, they are a carrier but typically do not show symptoms of FMF. However, carriers can pass the mutated gene to their children. If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two mutated genes and develop FMF, a 50% chance their child will be a carrier, and a 25% chance their child will inherit two normal genes and be unaffected.

Symptoms and Triggers

The manifestations of FMF are diverse and can vary significantly among individuals. The most prominent symptom is recurrent fever, which can reach high temperatures (38-40°C or 100.4-104°F) and typically lasts for 1 to 3 days. Accompanying the fever are episodes of inflammation, which most commonly affect:

• Abdomen: This is the most frequent site of inflammation, causing severe abdominal pain, mimicking appendicitis or peritonitis.
• Chest: Pleuritis, or inflammation of the lining of the lungs, can cause sharp chest pain, especially during breathing.
• Joints: Arthritis, particularly affecting the larger joints like the knees, ankles, and hips, leads to pain, swelling, and limited mobility.
• Skin: Erythema nodosum, a type of skin inflammation causing tender red nodules, often on the shins, can occur.

While the exact triggers for FMF attacks are not fully understood, some individuals report that stress, physical exertion, menstruation, or certain infections can precipitate an episode. The unpredictable nature of these attacks is a significant burden for patients.

Diagnosis and Management

Diagnosing FMF can be challenging due to the episodic nature of symptoms and the overlap with other conditions. Diagnosis is typically based on clinical criteria, family history, and genetic testing for MEFV gene mutations. Blood tests may show elevated inflammatory markers during an attack. The primary treatment for FMF is a daily oral medication called colchicine. Colchicine is highly effective in preventing attacks and reducing the risk of complications, particularly amyloidosis. For individuals who cannot tolerate colchicine or do not respond adequately, other medications that target inflammation, such as biologics (e.g., anakinra, canakinumab), may be used. Long-term management involves consistent medication adherence and regular medical follow-up to monitor for potential complications.

Complications of Untreated FMF

If left untreated or inadequately managed, FMF can lead to serious long-term complications. The most significant is amyloidosis, a condition where abnormal proteins (amyloid) build up in organs, most notably the kidneys. This can lead to kidney failure, requiring dialysis or transplantation. Other potential complications include chronic joint damage, infertility, and an increased risk of cardiovascular disease.